Skip to main content
FinSpry Logo
FinSpry
QGEN logo
QGEN
(NYSE)
Qiagen N.V.
$41.03-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Qiagen (QGEN) Stock Price & Financial Analysis

Qiagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$39.75 - $41.10
52-Week High$57.82
52-Week Low$38.13
Open$39.91
Volume1.28M
Average Volume (3M)1.28M
Market Cap8.53B
Shares Outstanding207.94M
P/E Ratio (TTM)19.76
Forward P/E9.87
Price to Sales (P/S)4.02
Price to Book (P/B)2.22
EV/EBITDA14.53
Revenue (TTM)2.09B
Net Income (TTM)424.88M
Free Cash Flow (TTM)447.87M
EPS (TTM)$2.05
Profit Margin20.33%
Operating Margin26.43%
Return on Equity (ROE)11.25%
Debt to Equity0.44
50-Day MA$47.02
200-Day MA$47.88
52-Week Change2.23%
Annual Dividend$2.66
Dividend Yield6.59%
Payout Ratio130.10%
Last Dividend Ex-DateJan 8, 2026

Frequently Asked Questions About Qiagen

What is the current stock price for QGEN?

As of the latest trading session, QGEN stock trades at $41.03. The 52-week range is $38.13–$57.82, with a day range of $39.75–$41.10.

What is the P/E ratio for QGEN?

Qiagen's trailing P/E ratio is 19.8, meaning investors pay $19.8 for every $1 of annual earnings. The forward P/E is 9.9, reflecting analyst expectations for future earnings. Qiagen operates in the Healthcare sector.

Does QGEN pay dividends?

Yes, Qiagen pays a 6.59% annual dividend yield ($2.66 per share). The payout ratio is 130.1%. The last ex-dividend date was 2026-01-08.

What do analysts recommend for QGEN?

Based on 4 analysts, the consensus for QGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of QGEN?

Qiagen's market capitalization is $8.53B, classifying it as a mid-cap company. Qiagen operates in the Healthcare sector within the Diagnostics & Research industry.